Last updated: 2026-10-01 09:10:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Nexentis Technologies Inc. (NXTS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.40, with a market capitalization of $2.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.14 to $23.80. This page covers its latest market performance, valuation, price trends and company information.
$2.03M | |
$1.40 | |
$23.80 | |
$1.14 | |
$1.39 | |
-- | |
62.85K | |
-- | |
$23.80 | |
$1.14 | |
-- | |
-- |
Nexentis Technologies Inc. (NXTS) is trading at $1.40 in pre-market trading as of 2026-10-01 08:01:00, up 0.43% ($0.01) from the previous close of $1.39
Pre-market trading shows how investors are pricing NXTS before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Nexentis Technologies Inc. (NXTS) moved from $1.41 to $1.40, representing a decline of 0.99% ($0.01).
The stock traded between $1.14 and $1.66 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 87.16 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.1%
NXTS is currently trading at $1.40, placing it 1.1% of the way from its 52-week low of $1.14 to its 52-week high of $23.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nexentis Technologies Inc. (NXTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.